HER2 mutations in NSCLC
By Fernando López-Ríos
Learn how to apply best practices for detection of HER2 mutations in NSCLC and current and emerging targeted treatment options for HER2-positive patients.
Register to access
Learning objectives
After completing this activity, you will be able to:
- Describe the incidence and characteristics associated with HER2 mutations in NSCLC
- Select appropriate biomarker tests to inform treatment selection for patients with HER2 mutation-positive NSCLC
- Integrate new clinical data on targeted therapies into clinical practice to create individualized treatment plans for patients with HER2 mutation-positive NSCLC
Activity overview
These simulation-based case studies are available with video and text. The activity is best supported via a computer or mobile device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari.
Release date: 17th March 2025
Estimated time to complete: 15 minutes